Research program Live corpus

Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.

PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 40,255 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

Explore Platform → See latest papers

40,255 Papers indexed

1,440 Papers AI scored

40,255 Ranked papers

100.0% Coverage

Featured discovery ● Live

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

AI Score 79.80 Active signal

Grade A

Final score 88.16

Narrative velocity Not calculated

Confidence Building

CHIP-AML22 is a multinational pediatric de novo AML trial protocol integrating risk-adapted therapy, randomized gemtuzumab ozogamicin and consolidation-course comparisons, subgroup-specific quizartinib, and toxicity-reduction measures.

Read full analysis →

LIVE PEDIATRIC ONCOLOGY INTELLIGENCE

↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing

TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

Published Jun 20, 2026

Journal Trials

88.16 Ranking score

A grade PMID 42321916

View analysis →

Bicistronic CD19/CD22 CAR T-Cell Therapy in Pediatric B-Cell Acute Lymphoblastic Leukemia: A Nonrandomized Clinical Trial.

Published Sep 03, 2026

Journal JAMA oncology

87.88 Ranking score

A grade PMID 42690647

View analysis →

Targeting homologous recombination deficiency with intensified chemotherapy versus standard chemotherapy followed by olaparib in stage III breast cancer (SUBITO): an open-label, randomised, controlled, phase 3 trial.

Published Jul 01, 2026

Journal The Lancet. Oncology

87.73 Ranking score

A grade PMID 42372741

View analysis →

Umbilical cord blood natural killer cells improve anti-GD2 antibody efficacy in neuroblastoma: from mouse to human.

Published May 30, 2026

Journal Oncoimmunology

87.38 Ranking score

A grade PMID 42216567

View analysis →

Medial retropharyngeal nodal region sparing radiotherapy in nasopharyngeal carcinoma: five year analysis of open label, non-inferiority, multicentre, randomised phase 3 trial.

Published Mar 31, 2026

Journal BMJ (Clinical research ed.)

87.15 Ranking score

A grade PMID 41916649

View analysis →

Therapy and biomarker dependent progression-free survival in infant sonic hedgehog medulloblastoma: a multi-national retrospective cohort study.

Published May 18, 2026

Journal EClinicalMedicine

86.97 Ranking score

A grade PMID 42382416

View analysis →

Integrated biomarker and treatment correlates of prognosis in infant non-WNT/non-SHH medulloblastoma: a multinational retrospective cohort study.

Published May 18, 2026

Journal The Lancet. Child & adolescent health

85.99 Ranking score

A grade PMID 42150584

View analysis →

Blinatumomab for Replacing Chemotherapy in Pediatric Acute Lymphoblastic Leukemia.

Published Sep 17, 2026

Journal The New England journal of medicine

85.54 Ranking score

B grade PMID 42748428

View analysis →

Daraxonrasib (RMC-6236) is an effective targeted therapy for RAS -mutant neuroblastoma.

Published Feb 20, 2026

Journal bioRxiv : the preprint server for biology

85.22 Ranking score

A grade PMID 41756844

View analysis →

A Phase I/II Trial of Anti-CD22/CD19 CAR-T Cell Therapy, CART2219.1, in Adult and Pediatric Relapsed/Refractory B-ALL.

Published Sep 21, 2026

Journal Blood cancer discovery

85.08 Ranking score

A grade PMID 42765973

View analysis →

T-cell receptor-engineered T-cell therapy using a glypican-3-specific TCR derived from a hepatoblastoma vaccine responder for HLA-A2-positive glypican-3-expressing cancers.

Published Jun 26, 2026

Journal Cancer letters

85.07 Ranking score

A grade PMID 42362103

View analysis →

Gilteritinib and chemotherapy in children with relapsed/refractory FLT3-ITD AML: results from the phase 1/2 SKIPPER trial.

Published Jul 14, 2026

Journal Blood advances

84.86 Ranking score

A grade PMID 42101908

View analysis →

LATEST PEDIATRIC CANCER PAPERS

Database feed

Last ingest 2026-11-09 10:15 AM

1 Distance and interruption: The violence of deportation among families enduring childhood cancer in the United States. Medical anthropology quarterly — Nov 09, 2026 2 Beyond hemoglobin thresholds: identifying clinical predictors for red blood cell transfusion in pediatric severe anemia. Pediatric research — Nov 09, 2026 3 Exploring the Limits of Robotic Surgery for Wilms Tumor: A Descriptive Analysis. European urology oncology — Nov 09, 2026 4 Effectiveness of Upfront Radiotherapy in Central Nervous System Germ Cell Tumors. Practical radiation oncology — Nov 09, 2026 5 Integrative network toxicology and clinical validation identify CD4, PTGS2, and KDR as candidate targets of nicotine in infantile hemangioma. Gene — Nov 09, 2026 6 Characterization of N-glycosylation remodeling in cerebrospinal fluid extracellular vesicles in children with purulent meningitis and viral meningitis: an exploratory glycomics study based on MALDI-TOF/TOF-MS. Glycoconjugate journal — Nov 09, 2026 7 Willingness to participate and model preference for integrated medical and elderly care among older patients with cancer in China: a cross sectional study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer — Nov 09, 2026 8 Public Participation in U.S. Food and Drug Administration (FDA) Advisory Committees: A Qualitative Analysis. Therapeutic innovation & regulatory science — Nov 09, 2026

WHAT THE AI SEES TODAY

Live pediatric oncology intelligence

● Live

↗

Therapeutic signal strength is updating across newly scored pediatric oncology literature.

✦

Mechanism clusters are forming around tumor biology, immune response, targeted therapy, treatment resistance, and drug repurposing.

⌁

Daily literature intake feeds the ranking engine and refreshes study-design, human-relevance, and therapeutic-relevance scores.

●

40,255 pediatric cancer records are currently visible under this search.

PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

40255 results

Presumed Bilateral Ciliary Body Medulloepithelioma in a Child with Pleuropulmonary Blastoma and DICER1 Mutation.

PMID 40150037 Published: 2025-03-11 Ingested: 2026-08-02 12:04 AM Diagnostics (Basel, Switzerland)

AI -

Standard 51.3

Final -

AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 51.3/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 34.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

Case Report: Unmasking a sporadic pediatric tumor emergency: superior vena cava syndrome.

PMID 40123670 Published: 2025-03-07 Ingested: 2026-08-02 12:03 AM Frontiers in pediatrics

AI -

Standard 51.3

Final -

AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 51.3/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 34.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

Unilateral parotid gland double hemangiomas in an infant: A rare case report.

PMID 40017713 Published: 2024-09-28 Ingested: 2026-08-02 12:02 AM Radiology case reports

AI -

Standard 51.3

Final -

AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 51.3/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 34.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

Parotid rhabdomyosarcoma with spindle cell features masquerading as a benign salivary gland tumour: Pitfall alert.

PMID 39983335 Published: 2025-02-20 Ingested: 2026-08-02 12:03 AM Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia

AI -

Standard 51.3

Final -

AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 51.3/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 44.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

Dieulafoy Lesion in a Pediatric Patient.

PMID 39982012 Published: 2025-02-21 Ingested: 2026-08-02 12:03 AM Pediatric emergency care

AI -

Standard 51.3

Final -

AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 51.3/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 34.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

A Rare Case of Juvenile Granulosa Cell Tumor in a Premenarchal Female: Clinical Presentation, Diagnosis, and Management.

PMID 39877787 Published: 2024-12-28 Ingested: 2026-08-02 12:03 AM Cureus

AI -

Standard 51.3

Final -

AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 51.3/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 44.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

Uncommon Extradural Spinal Fibrolipoma in a Child: A Case Report.

PMID 39834672 Published: 2025-01-16 Ingested: 2026-08-02 12:03 AM Cureus

AI -

Standard 51.3

Final -

AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 51.3/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 34.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

Subcutaneous Panniculitis-Like T-Cell Lymphoma Presenting as a Targetoid Plaque in a Pediatric Patient: A Case Report and Review of Literature.

PMID 39805581 Published: 2025-01-13 Ingested: 2026-08-02 12:03 AM Pediatric dermatology

AI -

Standard 51.3

Final -

AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 51.3/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 44.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

Interdisciplinary care of facial plexiform neurofibroma: a case report.

PMID 39574127 Published: 2024-11-21 Ingested: 2026-08-02 12:02 AM Journal of medical case reports

AI -

Standard 51.3

Final -

AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 51.3/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 34.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

Innovative Combination of Tetracycline Rinse and CO₂ Laser Ablation for Treating White Sponge Nevus in Adolescents: A Case Study.

PMID 39563015 Published: 2024-11-20 Ingested: 2026-08-02 12:02 AM The American journal of case reports

AI -

Standard 51.3

Final -

AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 51.3/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 34.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

Delayed En Bloc Excision of L3 for Metastatic Sacrococcygeal Teratoma on a 1-Year-Old Boy: A Case Report.

PMID 39446987 Published: 2024-10-24 Ingested: 2026-08-02 12:02 AM JBJS case connector

AI -

Standard 51.3

Final -

AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 51.3/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 44.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

Hemangioma of the Tongue: A Case Report.

PMID 39286704 Published: 2024-08-16 Ingested: 2026-08-02 12:02 AM Cureus

AI -

Standard 51.3

Final -

AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 51.3/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 34.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

Page 2868 of 3355

Open the Research
Intelligence Map

Finding therapies hidden in 40,255 pediatric cancer papers.

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

Ranked Discovery Journal Articles

Database feed

All ranked pediatric cancer papers

AI-assisted research information

Open the Research Intelligence Map